BIOMAT Database Logo BIOMAT Database Logo

Factitious hypermineralcorticoidism by chronic use of 9-alpha-fluoroprednisolone containing collyrium. 1989

M Errico, and M Freda, and M Zingrillo, and M Grilli

UI MeSH Term Description Entries
D009883 Ophthalmic Solutions Sterile solutions that are intended for instillation into the eye. It does not include solutions for cleaning eyeglasses or CONTACT LENS SOLUTIONS. Eye Drop,Eyedrop,Eyedrops,Ophthalmic Solution,Eye Drops,Drop, Eye,Drops, Eye,Solution, Ophthalmic,Solutions, Ophthalmic
D003233 Conjunctivitis, Allergic Conjunctivitis due to hypersensitivity to various allergens. Allergic Conjunctivitis,Conjunctivitis, Atopic,Conjunctivitis, Giant Papillary,Conjunctivitis, Vernal,Keratoconjunctivitis, Vernal,Allergic Conjunctivitides,Atopic Conjunctivitides,Atopic Conjunctivitis,Conjunctivitides, Allergic,Conjunctivitides, Atopic,Conjunctivitides, Giant Papillary,Conjunctivitides, Vernal,Giant Papillary Conjunctivitides,Giant Papillary Conjunctivitis,Keratoconjunctivitides, Vernal,Papillary Conjunctivitides, Giant,Papillary Conjunctivitis, Giant,Vernal Conjunctivitides,Vernal Conjunctivitis,Vernal Keratoconjunctivitides,Vernal Keratoconjunctivitis
D005162 Factitious Disorders Disorders characterized by physical or psychological symptoms that are not real, genuine, or natural. Ganser Syndrome,Pseudodementia,Pseudopsychosis,Disorders, Factitious,Syndrome, Ganser
D005260 Female Females
D005477 Fluprednisolone A synthetic glucocorticoid with anti-inflammatory properties.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Errico, and M Freda, and M Zingrillo, and M Grilli
[Hypermineralcorticism caused by topical preparation containing 9-alpha-fluoroprednisolone].
January 1988, Medicina cutanea ibero-latino-americana,
M Errico, and M Freda, and M Zingrillo, and M Grilli
[Normotensive hypermineralocorticism caused by abusive use of a nasal spray containing 9 alpha-fluoroprednisolone].
January 1984, Minerva endocrinologica,
M Errico, and M Freda, and M Zingrillo, and M Grilli
[Exogenous hypermineralocorticism caused by a nasal spray containing 9-alpha fluoroprednisolone].
January 1984, Minerva cardioangiologica,
M Errico, and M Freda, and M Zingrillo, and M Grilli
Mineralocorticoid hypertension due to a nasal spray containing 9 alpha-fluoroprednisolone.
September 1981, The American journal of medicine,
M Errico, and M Freda, and M Zingrillo, and M Grilli
[Excess mineralocorticoid syndrome secondary to nasal sprays containing 9 alpha-fluoroprednisolone].
September 1987, Minerva medica,
M Errico, and M Freda, and M Zingrillo, and M Grilli
Hypokalaemic hypertension due to a nasal spray containing 9 alpha fluoroprednisolone.
June 1984, Human toxicology,
M Errico, and M Freda, and M Zingrillo, and M Grilli
Hypokalemic rhabdomyolysis secondary to pseudohyperaldosteronism due to the use of a lotion containing 9-alpha-fluoroprednisolone.
January 1986, Nephron,
M Errico, and M Freda, and M Zingrillo, and M Grilli
[Case of pseudohyperaldosteronism caused by 9-alpha-fluoroprednisolone abuse].
July 1985, La Clinica terapeutica,
M Errico, and M Freda, and M Zingrillo, and M Grilli
[9-alpha-fluoroprednisolone in hepatic regeneration].
September 1958, Rivista di patologia e clinica,
M Errico, and M Freda, and M Zingrillo, and M Grilli
[A hypokalemic normotensive variant of the syndrome caused by nasal spray containing 9-alpha-fluoroprednisolone].
January 1985, La Clinica terapeutica,
Copied contents to your clipboard!